Left: Tariq Abu-Naaj; right: Dr. med. Roland Kuster
Thorax Switzerland: together in search of clarity and support
The driving forces behind Thorax Switzerland are Dr. med. Roland Kuster and Tariq Abu-Naaj. With decades of experience in thoracic surgery, Dr. Kuster moved into medical management after a serious accident. Tariq Abu-Naaj, owner of Medical Brand, is involved in marketing for hospitals and medical professionals in Germany, Austria and Switzerland. He is particularly committed to ensuring that clinics take the perspective of patients into account in an exceptional and comprehensive way.
In a field that is unclear to many people—especially when it comes to thoracic medicine, where diagnoses are often serious and life-changing—the two have set themselves the goal of speaking with specialists across Switzerland in all areas of thoracic medicine. The aim: to create clarity and address the issues that truly matter to patients and their relatives.
Dr. med. Roland Kuster on the road for Thorax Switzerland
Thorax Switzerland is a long-term project that is expanded each month with additional contributions. Every question they receive is thoroughly examined by Dr. Kuster and Abu-Naaj in order to find satisfactory answers. They rely on blog posts as well as podcast interviews. The project is accompanied by a monthly newsletter that offers special topics for newsletter subscribers.
The Hirslanden Group, a private hospital group of Hirslanden AG in Switzerland with 17 clinics in 10 cantons and more than 3,000 attending physicians, supports the Thorax Switzerland project. This provides access to a unique network of resources and experts that leaves no questions unanswered. In addition, specialists from other clinics are warmly invited to participate in the project.
For Dr. Kuster and Abu-Naaj, the journey with Thorax Switzerland is a compelling search for answers to questions from patients and their relatives, in order to support them as effectively as possible. A journey they are looking forward to—one that helps shed more light on the often opaque field of thoracic medicine.
